Description of Collaborative Activity: |
Founded in September 2010, the NAASP is a public-private partnership designed to advance the National Strategy for Suicide Prevention in the United States. The NAASP's Research Prioritization Task Force (RPTF) was charged with developing a process to prioritize suicide prevention research efforts and consider ways to integrate science and service to ensure that suicide deaths decrease significantly within the next decade. The RPTF released the Nation's first suicide research agenda, A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives. The research agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20 percent in five years and by 40 percent or greater in ten years. In 2015, the RPTF produced the "U.S. National Suicide Prevention Research Efforts: 2008-2013 Portfolio Analyses." The analyses revealed that investments in suicide research are severely lagging, but there is a growing knowledge base of intervention research. In 2016, the NIH Office of Disease Prevention supported the Pathways to Prevention Workshop, Advancing Research to Prevent Youth Suicide in 2016, which further refined methodological challenges and data linkage needs relevant to multiple NIH Institutes and HHS agencies. The National Institute of Mental Health (NIMH) developed a request for information relevant to this workshop, and a federal partners meeting in the spring of 2017 considered additional actions in response to the workshop recommendations. Two multi-IC RFAs were issued in response to this effort (MH RFA 18-400; MH RFA 18-410). In 2016, NAASP adapted the goal of reducing US suicide rates by 20 percent in 10 years. NIMH supports this goal by identifying practice-ready suicide prevention research. For example, in May 2017, the NIMH led the meeting, the “State of Suicide Prevention in Emergency Care” with participation from the NIH Office of Emergency Care Research (NIGMS), SAMHSA, and the CDC. Surveillance, policy and practices challenges, as well as research gaps were identified for further strategic efforts. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
NIAAA, NIDA, NIMH, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP |
HHS Agency Collaborators on this Activity: |
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA |
